ClinicalTrials.Veeva

Menu

Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients

Loma Linda University (LLU) logo

Loma Linda University (LLU)

Status

Withdrawn

Conditions

Labor
Pregnant

Treatments

Drug: 5% lidocaine patch
Drug: placebo patch

Study type

Interventional

Funder types

Other

Identifiers

NCT01307839
5110014

Details and patient eligibility

About

Infiltration of the skin with lidocaine is standard practice prior to lumbar epidural placement in laboring parturients1. Skin infiltration, although brief, can be very stressful and painful for patients.2 This initial discomfort may cause patient anxiety, thus increasing the pain and decreasing the satisfaction with the procedure. To reduce this discomfort, various topical alternatives have been investigated with varying degrees of success.1-4 Now that a topical mixture of lidocaine that is safe and effective is available, the investigators would like to determine if it can reduce the pain of skin infiltration in particular and epidural placement as a whole.

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Laboring patients between the ages of 18 and 45 with a BMI of less than 45

Exclusion Criteria:

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

0 participants in 2 patient groups, including a placebo group

5% lidocaine patch
Active Comparator group
Description:
If the patient chooses to participate, the resident will place the patch over the lower lumbar area of the back.
Treatment:
Drug: 5% lidocaine patch
placebo patch
Placebo Comparator group
Description:
If the patient chooses to participate, the resident will place the patch over the lower lumbar area of the back.
Treatment:
Drug: placebo patch

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems